183 related articles for article (PubMed ID: 26806348)
1. AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin.
Couderc C; Boin A; Fuhrmann L; Vincent-Salomon A; Mandati V; Kieffer Y; Mechta-Grigoriou F; Del Maestro L; Chavrier P; Vallerand D; Brito I; Dubois T; De Koning L; Bouvard D; Louvard D; Gautreau A; Lallemand D
Neoplasia; 2016 Jan; 18(1):10-24. PubMed ID: 26806348
[TBL] [Abstract][Full Text] [Related]
2. KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.
Moleirinho S; Chang N; Sims AH; Tilston-Lünel AM; Angus L; Steele A; Boswell V; Barnett SC; Ormandy C; Faratian D; Gunn-Moore FJ; Reynolds PA
Oncogene; 2013 Apr; 32(14):1821-30. PubMed ID: 22614006
[TBL] [Abstract][Full Text] [Related]
3. AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis.
Zhou Y; Zhang J; Li H; Huang T; Wong CC; Wu F; Wu M; Weng N; Liu L; Cheng ASL; Yu J; Wong N; Lo KW; Tang PMK; Kang W; To KF
Oncogene; 2020 May; 39(22):4375-4389. PubMed ID: 32313226
[TBL] [Abstract][Full Text] [Related]
4. NEDD4L-mediated Merlin ubiquitination facilitates Hippo pathway activation.
Wei Y; Yee PP; Liu Z; Zhang L; Guo H; Zheng H; Anderson B; Gulley M; Li W
EMBO Rep; 2020 Dec; 21(12):e50642. PubMed ID: 33058421
[TBL] [Abstract][Full Text] [Related]
5. The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP.
Striedinger K; VandenBerg SR; Baia GS; McDermott MW; Gutmann DH; Lal A
Neoplasia; 2008 Nov; 10(11):1204-12. PubMed ID: 18953429
[TBL] [Abstract][Full Text] [Related]
6. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
[TBL] [Abstract][Full Text] [Related]
7. Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer.
Morrow KA; Das S; Meng E; Menezes ME; Bailey SK; Metge BJ; Buchsbaum DJ; Samant RS; Shevde LA
Oncotarget; 2016 Apr; 7(14):17991-8005. PubMed ID: 26908451
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase.
Serrano I; McDonald PC; Lock F; Muller WJ; Dedhar S
Nat Commun; 2013; 4():2976. PubMed ID: 24356468
[TBL] [Abstract][Full Text] [Related]
9. Loss of tumor suppressor Merlin in advanced breast cancer is due to post-translational regulation.
Morrow KA; Das S; Metge BJ; Ye K; Mulekar MS; Tucker JA; Samant RS; Shevde LA
J Biol Chem; 2011 Nov; 286(46):40376-85. PubMed ID: 21965655
[TBL] [Abstract][Full Text] [Related]
10. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
11. Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway.
Hsu YL; Hou MF; Kuo PL; Huang YF; Tsai EM
Oncogene; 2013 Sep; 32(37):4436-47. PubMed ID: 23045282
[TBL] [Abstract][Full Text] [Related]
12. NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition.
Garcia-Rendueles ME; Ricarte-Filho JC; Untch BR; Landa I; Knauf JA; Voza F; Smith VE; Ganly I; Taylor BS; Persaud Y; Oler G; Fang Y; Jhanwar SC; Viale A; Heguy A; Huberman KH; Giancotti F; Ghossein R; Fagin JA
Cancer Discov; 2015 Nov; 5(11):1178-93. PubMed ID: 26359368
[TBL] [Abstract][Full Text] [Related]
13. IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway.
Lu J; Yang Y; Guo G; Liu Y; Zhang Z; Dong S; Nan Y; Zhao Z; Zhong Y; Huang Q
Oncotarget; 2017 Jul; 8(30):49502-49514. PubMed ID: 28548934
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the Hippo Pathway by Phosphatidic Acid-Mediated Lipid-Protein Interaction.
Han H; Qi R; Zhou JJ; Ta AP; Yang B; Nakaoka HJ; Seo G; Guan KL; Luo R; Wang W
Mol Cell; 2018 Oct; 72(2):328-340.e8. PubMed ID: 30293781
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation.
Sekido Y
Pathol Int; 2011 Jun; 61(6):331-44. PubMed ID: 21615608
[TBL] [Abstract][Full Text] [Related]
16. RICH1 inhibits breast cancer stem cell traits through activating kinases cascade of Hippo signaling by competing with Merlin for binding to Amot-p80.
Tian Q; Gao H; Zhou Y; Zhu L; Yang J; Wang B; Liu P; Yang J
Cell Death Dis; 2022 Jan; 13(1):71. PubMed ID: 35064101
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of tumor suppressor Merlin facilitates metabolic adaptation by co-operative engagement of SMAD-Hippo signaling in breast cancer.
Mota MSV; Jackson WP; Bailey SK; Vayalil P; Landar A; Rostas JW; Mulekar MS; Samant RS; Shevde LA
Carcinogenesis; 2018 Sep; 39(9):1165-1175. PubMed ID: 29893810
[TBL] [Abstract][Full Text] [Related]
18. Activation of Yes-Associated Protein in Low-Grade Meningiomas Is Regulated by Merlin, Cell Density, and Extracellular Matrix Stiffness.
Tanahashi K; Natsume A; Ohka F; Motomura K; Alim A; Tanaka I; Senga T; Harada I; Fukuyama R; Sumiyoshi N; Sekido Y; Wakabayashi T
J Neuropathol Exp Neurol; 2015 Jul; 74(7):704-9. PubMed ID: 26049897
[TBL] [Abstract][Full Text] [Related]
19. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes.
Mizuno T; Murakami H; Fujii M; Ishiguro F; Tanaka I; Kondo Y; Akatsuka S; Toyokuni S; Yokoi K; Osada H; Sekido Y
Oncogene; 2012 Dec; 31(49):5117-22. PubMed ID: 22286761
[TBL] [Abstract][Full Text] [Related]
20. [Research progress of Merlin protein and its signal pathway in tumor].
Zhu YJ; Shan CG
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(9):757-762. PubMed ID: 29771032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]